Delek Group Ltd. Invests $641,000 in Evogene Ltd (EVGN)

Delek Group Ltd. bought a new stake in Evogene Ltd (NASDAQ:EVGN) in the fourth quarter, HoldingsChannel reports. The institutional investor bought 209,108 shares of the biotechnology company’s stock, valued at approximately $641,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Jane Street Group LLC raised its stake in shares of Evogene by 393.9% in the fourth quarter. Jane Street Group LLC now owns 85,167 shares of the biotechnology company’s stock valued at $262,000 after purchasing an additional 67,923 shares in the last quarter. Harel Insurance Investments & Financial Services Ltd. acquired a new position in shares of Evogene in the fourth quarter valued at $424,000. Finally, Vanguard Group Inc. raised its stake in shares of Evogene by 4.2% in the second quarter. Vanguard Group Inc. now owns 436,225 shares of the biotechnology company’s stock valued at $2,443,000 after purchasing an additional 17,391 shares in the last quarter. Institutional investors and hedge funds own 35.47% of the company’s stock.

How to Become a New Pot Stock Millionaire

Separately, ValuEngine lowered Evogene from a “sell” rating to a “strong sell” rating in a research note on Friday, March 2nd.

Shares of EVGN stock opened at $3.35 on Friday. Evogene Ltd has a 1 year low of $2.66 and a 1 year high of $5.74. The firm has a market capitalization of $89.35, a price-to-earnings ratio of -4.14 and a beta of 0.65.

Evogene (NASDAQ:EVGN) last announced its quarterly earnings results on Wednesday, February 28th. The biotechnology company reported ($0.24) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.03). Evogene had a negative net margin of 616.33% and a negative return on equity of 27.15%. The company had revenue of $0.73 million during the quarter. equities analysts expect that Evogene Ltd will post -0.75 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: “Delek Group Ltd. Invests $641,000 in Evogene Ltd (EVGN)” was published by Ticker Report and is the property of of Ticker Report. If you are reading this piece on another website, it was illegally stolen and republished in violation of United States & international copyright & trademark legislation. The legal version of this piece can be accessed at https://www.tickerreport.com/banking-finance/3295273/delek-group-ltd-invests-641000-in-evogene-ltd-evgn.html.

Evogene Company Profile

Evogene Ltd. (Evogene) is a biotechnology company for the improvement of crop productivity. The Company is engaged in developing seed traits for improved yield and abiotic stress tolerance, seed traits for biotic stress resistance, herbicides and bio-stimulants. The Company operates a seed business under its subsidiary Evofuel Ltd.

Want to see what other hedge funds are holding EVGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Evogene Ltd (NASDAQ:EVGN).

Institutional Ownership by Quarter for Evogene (NASDAQ:EVGN)

Receive News & Ratings for Evogene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evogene and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Brokerages Expect Capital Product Partners L.P.  Will Announce Quarterly Sales of $59.70 Million
Brokerages Expect Capital Product Partners L.P. Will Announce Quarterly Sales of $59.70 Million
Analysts Set Fleetcor  Target Price at $208.00
Analysts Set Fleetcor Target Price at $208.00
Avianca Holdings SA  Receives $10.33 Average PT from Analysts
Avianca Holdings SA Receives $10.33 Average PT from Analysts
Somewhat Favorable News Coverage Somewhat Unlikely to Affect Kayne Anderson Energy Development  Stock Price
Somewhat Favorable News Coverage Somewhat Unlikely to Affect Kayne Anderson Energy Development Stock Price
Comparing Evogene  & SenesTech
Comparing Evogene & SenesTech
Hi Crush Partners  versus Its Peers Financial Survey
Hi Crush Partners versus Its Peers Financial Survey


© 2006-2018 Ticker Report. Google+.